Sign in to continue:

Wednesday, January 28th, 2026

Malayan Banking Positioned for Growth: Beneficiary of Positive Johor Economic Developments

Date: October 8, 2024
Broker: CGS International


Company Overview

Malayan Banking Berhad (Maybank) is one of Malaysia’s largest financial institutions, with a strong presence in Southeast Asia. The company is well-positioned to benefit from positive economic developments in the region, particularly in Johor and Singapore.


Growth Opportunities

Maybank is expected to be the largest banking beneficiary of the economic growth in Johor, driven by its strong exposure in both Malaysia and Singapore. These economic developments provide significant opportunities for Maybank’s operations in the region.


Performance in Indonesia

Maybank Indonesia (Maybank INDO) has experienced a decline in its Profit Before Tax (PTP) in the first half of 2024, largely due to corporate provisioning. However, Maybank INDO expects its PTP to recover sequentially in the second half of the year. This recovery is anticipated to come from improvements in corporate provisioning, positioning the Indonesian operations for stronger performance going forward.


Investment Outlook

The report maintains an “Add” rating for Maybank, supported by its robust fee income, effective capital management, and initiatives to enhance dividend yields and Return on Equity (ROE). These factors make Maybank an attractive investment in the financial sector.


Conclusion

Maybank’s strong presence in Malaysia, Singapore, and Indonesia, combined with its strategic capital management, positions the bank well to capitalize on regional economic growth. The bank’s potential for recovery in Indonesia and its strong fee income generation further support its positive outlook.

DBS Group, OCBC, United Overseas Bank

DBS Group, OCBC, United Overseas Bank 🏦 DBS Group (DBS SP) – Cautious Outlook Amid Limited Upside Recommendation: HOLD Target Price: S$37.30 Stop Loss: Not specified Date of Recommendation: 2nd September 2024 Broker: CGS-CIMB...

Hyphens Pharma International (HYP) 2025 Outlook: Higher Margins, Portfolio Optimization & Growth Targets in Southeast Asia

CGS International August 20, 2025 Hyphens Pharma International: Strategic Portfolio Shift Drives Margin Growth Despite Revenue Dip Executive Summary: Navigating a Pivotal Transition in Hyphens Pharma International Hyphens Pharma International (SGX: HYP), a leading...

Malaysian Stock Market Outlook: Top Picks and Technical Analysis for November 2024

Comprehensive Analysis of Malaysian Stocks – November 2024 Comprehensive Analysis of Malaysian Stocks – November 2024 Report by CGS International | November 18, 2024 Wellcall Holdings: Extending Its Upward Channel Wellcall Holdings has been...